Discovery™ IQ Gen 2
High-sensitivity PET/CT hybrid system with BGO detector and Q.Clear quantitative reconstruction
Clear the path to clear images
With MotionFree technology, Discovery™ IQ Gen 2 ensures respiratory motion correction for every patient without bulky accessories.
Class-Leading Sensitivity
Up to 22 cps/kBq for ultra-fast whole-body acquisitions in as little as 4 minutes.
Q.Clear Reconstruction
Up to 2x improvement in contrast-to-noise ratio to identify early tumor lesions.
Scalable Ring Detector
Lets you extend the axial coverage length as the clinical demand of your service grows.
Lesion detection and accurate quantification with Discovery™ IQ Gen 2
Uncompromising quantitative accuracy for oncologic staging
Accurate quantitative SUV to evaluate treatment response
Q.Clear's reproducible SUV quantification lets oncologists measure with millimetric precision whether a tumor is responding to chemotherapy or immunotherapy.
Its optimized BGO detector delivers extraordinary sensitivity with a significant reduction in the administered tracer dose.
Patient comfort and low dose
Allows the injected activity to be cut in half without losing diagnostic quality.
Integrated multislice CT scanner
Integrated CT that provides accurate attenuation maps and complete diagnostic anatomical detail.
Want to expand your molecular oncology service with PET/CT?
Consult with our Global Médica specialists for personalized technical advice, demonstrations, and institutional quotes.